Cannacor (Pty) Ltd
Cannacor (Pty) Ltd
Token: CANO

Where Cannabis Cultivation and Blockchain Technology Combine Seamlessly

PreICO dates
Start date: 2019-09-11
End date: 2019-12-15

ICO dates
Start date: 2019-12-16
End date: 2020-03-31

Registrated in: Lesotho

Platform: Ethereum
Type: Utility


Cannacor (Pty) Ltd categories
Big Data Business services Cryptocurrency Infrastructure Internet Investment Manufacturing Platform Smart Contract Software
Cannacor (Pty) Ltd token sale
KYC passing required No | Whitelist No | Restriction for countries Lesotho,Singapore
Soft cap 1,500,000 USD
Hard cap 112,300,000 USD
Tokens for sale 1,200,000,000
Token distribution in ICO
Price 1 CANO = 0.0003 USD
Minimal investment $50
Acceppting ETH
CannaCor and Blockchain Corporation are collaborating with a common vision to bring lasting change in the field of cannabis research, cultivation, processing and distribution. Our goal is to transform the entire cannabis cultivation process to make it as transparent and secure as possible.

  • CannaCor (Pty) Ltd is an incorporated company under the Companies Act of 2011 in the Kingdom of Lesotho with Registration Number 65263 and TIN number 200084029-4.
  • CannaCor is licensed as a prohibited drug operator. The license is granted under Section 12 of the Drug Abuse Act of 2008 with license number 02/D022/06-2019.
  • CannaCor has obtained 50 000m2 of land in Berea, Lesotho, of which 30 000m2 is permitted for greenhouse or indoor cultivation of Cannabis.
  • CannaCor intends to commence with the development of an aquaponics production facility for medical cannabis during the fourth quarter of 2019.
  • The company will be able to serve Canada, Europe and other global markets from this facility.
  • The Cannacor team will ensure that they are compliant with every aspect of the act and are certified by the following: ISO 9001, Good Agricultural and Collecting Practice (GACP), Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP).


The vision of CannaCor is to become a frontrunner of medical cannabis cultivation in Lesotho. Our focus is to implement sustainable production facilities and expand our lead with an aquaponics production plant while integrating all our management systems with a selection of blockchain technologies to ensure transparency, immutability and real-life tracking.


CannaCor works with a group of experienced scientists, blockchain developers, pharmacists and engineers daily, with the goal of improving our company by researching and delivering environmentally sustainable high-quality cannabis products.

The Cannacor Cultivation facility

Cannacor’s objective is to develop its own aquaponics cultivation and production facility for medical cannabis on the company’s premises in Lesotho. This will enable the company to meet a growing demand in a global market of scarce production capacity and become a recognized supplier to the global markets that have no or limited production capacity.

The intention is to establish a facility where standardized, uniform and consistent products can be cultivated, without the use of pesticides, so that the content of the active ingredients is the same for each harvesting and processing stage. The development of the cultivation premises into a complete facility for the cultivation and production of medical cannabis is expected to commence in the fourth quarter of 2019.

Cannacor (Pty) Ltd news, social
Cannacor (Pty) Ltd search trends in Google

Cannacor (Pty) Ltd Roadmap

Q4 2018
Research and brainstorm sessions initiated to establish most viable
solution to cultivate medical cannabis
Current technologies researched to establish the CannaCor
Various blockchain technologies researched to manage the medical
cannabis cultivation life cycle and supply chain management systems
Strategic alliances formed with blockchain developers, cultivators
and pioneers in the cannabis industry
Company incorporated in Lesotho, southern Africa, to operate the
following business activities:
- growing of drug and pharmaceutical crops
- wholesale and/or retail sale of pharmaceutical and medical goods.
Q1 2019
50 000 m2 agricultural land acquired in Lesotho, southern Africa, for
the cultivation of medical cannabis
Environmental Impact Assessment (EIA) curated and submitted
Licence application lodged with the Drug Control Authorities in
Lesotho to obtain:
- authorization for export and import of medical cannabis
- authorization to produce medical cannabis products
Q2 2019
Blockchain developer and ICO marketing team appointed
Greenpaper development
Design of cannabis cultivation plant.
Q3 2019
CannaCor medical cannabis cultivation licence approved
New website design / landing page
Wallets and user administration panel development
Greenpaper updated and new corporate identity incorporated
Pre-ICO round starts 11 September 2019 and ends 15 December
Q4 2019
- Design of cultivation plant, testing laboratory and packaging plant
-Construction of cultivation facility
- Blockchain and Hyperledger Fabric application development,
incorporating QR code labelling, product traceability, drug
authentication, production life cycle management and supply chain
- New wallets and website release.
Q1 2020
- CannaCor application BETA testing
- First cannabis crops planted
- Application integration of production cycles
Q2 2020
First harvest, application integration of supply chain and first coin
Hugo van den Dool
Team member Hugo van den Dool CEO